Recherche
-
Targeting Pdzrn3 maintains adult blood-brain barrier and central nervous system homeostasis
(Journal of Cerebral Blood Flow and Metabolism. pp. 271678X211048981, 2021-10-13)Article de revueLibre accès -
Intrinsically impaired platelet production in some patients with persistent or chronic immune thrombocytopenia
(British Journal of Haematology. vol. 170, n° 3, pp. 408–415, 2015-08)Article de revueAccès réservé -
High sensitivity C reactive protein, fibrinogen levels and the onset of major depressive disorder in post-acute coronary syndrome
(BMC Cardiovascular Disorders. vol. 15, pp. 23, 2015-03-18)Article de revueLibre accès -
Clonal hematopoiesis are not associated with an increased systemic inflammation, ATHerosclerosis nor incidence of atherothrombosis: Results from the 3-city study (CHIP-3C)
(Atherosclerosis. vol. 355, pp. 29, 2022-08-01)Article de revueLibre accès -
L’accumulation de liquide dans l’espace extracellulaire du myocarde
(médecine/sciences. vol. 39, n° 3, pp. 293-295, 2023-03)Article de revueLibre accès -
Partial Mural Cell Ablation Disrupts Coronary Vasculature Integrity and Induces Systolic Dysfunction
(Journal of the American Heart Association, 2023-06-22)Article de revueLibre accès -
Correction: Autophagy protein 5 controls flow-dependent endothelial functions.
(Cellular and Molecular Life Sciences. vol. 80, n° 9, pp. 275, 2023-09-04)Article de revueLibre accès -
The skin autofluorescence may help to select patients with Type 2 diabetes candidates for screening to revascularization procedures
(Cardiovascular Diabetology. vol. 23, n° 1, pp. 32, 2024-01-13)Article de revueLibre accès -
Hospital medication adherence scale development in cardiovascular disorders
(Annales Pharmaceutiques Françaises, 2020-12-10)Article de revueLibre accès -
Validation d’une échelle de mesure de l’adhésion médicamenteuse cardiovasculaire utilisable en contexte hospitalier
(Annales Pharmaceutiques Françaises, 2020-02-11)Article de revueLibre accès